Researchers Identify Factors Associated With Hyperkalemia in CKD
In a study of chronic kidney disease patients not on dialysis, hyperkalemia developed in more women than men.
Nephrology Conferences
Vertebral Fracture Common in ESRD
In a small study, 34% of dialysis patients had vertebral fractures, and patients in the highest tertile of parathyroid hormone level had a nearly 3-fold increased risk of these fractures compared with those in the middle tertile.
Higher Vitamin D Target May Be Needed to Manage SHPT
New data support aggressive vitamin D repletion to a revised serum 25-hydroxyvitamin D target of at least 51 ng/mL in patients with chronic kidney disease.
Study: Dietary Potassium May Not Increase Hyperkalemia Risk in CKD
In a small study on nondialysis CKD patients, daily potassium intake was not associated with hyperkalemia (serum potassium level above 5 mEqL) in patients with chronic kidney disease.
Etelcalcetide Found to Increase Bone Mineral Density in SHPT
Markers of bone resorption decreased in hemodialysis patients with 6 months of etelcalcetide treatment.
Ankle-Brachial Index Predicts Vascular Calcification in SHPT
Analyses demonstrated that an ABI of 1.79 correlated with radiographic evidence of calcified vessels.
Epoetin Dose Linked With CVD, Mortality in Hemodialysis
Epoetin dose is significantly associated with cardiovascular disease whether patients had lower or higher hemoglobin levels, study finds.
IV Iron Therapy in CKD Increases Infection Risk
In a study, IV iron was associated with twice the risk for infections in CKD.
Thrice-Weekly Calcimimetic Dosing Feasible for SHPT
In a study, patients receiving cinacalcet under supervision 3 times per week after dialysis rather than after daily self-administration showed improvement in their parathyroid hormone levels.
Etelcalcetide Beneficial in Severe SHPT Uncontrolled With Cinacalcet
In a study, patients with uncontrolled SHPT were switched from oral cinacalcet to intravenous etelcalcetide.
-
Loading...
-
Loading...
Next post in Kidney Week 2018
